Drug can extend lives of cervical cancer patients

A drug that cuts the blood supply to tumours can significantly extend the lives of women with advanced cervical cancer, a study has shown.

Compared with those on chemotherapy alone, patients taking Avastin typically lived nearly four months longer.

The percentage of patients responding to therapy also increased by a third from 36% to almost half with the addition of Avastin.